These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 35031161)
1. Re: Trey Durdin, Alvin Goh, Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer? Eur Urol 2021;80:16-7: Transurethral Resection of Bladder Tumor in Diagnosis of Muscle-invasive Bladder Cancer: Old-fashioned Endoscopic Surgery is Here to Stay. Grobet-Jeandin E; Pinar U; Rouprêt M Eur Urol; 2022 Apr; 81(4):e94-e95. PubMed ID: 35031161 [No Abstract] [Full Text] [Related]
2. Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer? Bryan RT; Catto JWF; Jefferson KP; Patel P; James ND; On Behalf Of The BladderPath Trial Management Group Eur Urol; 2021 Jul; 80(1):18-19. PubMed ID: 33972095 [No Abstract] [Full Text] [Related]
3. Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36. Panebianco V; Del Giudice F; Narumi Y; Simone G; De Berardinis E; Catto JWF Eur Urol; 2021 Feb; 79(2):e52-e53. PubMed ID: 33261940 [No Abstract] [Full Text] [Related]
4. Re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Vila-Reyes H; DeCastro GJ; McKiernan JM Eur Urol; 2021 Jan; 79(1):e35-e36. PubMed ID: 32829975 [No Abstract] [Full Text] [Related]
5. Reply from authors re: Marko Babjuk. Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives. Eur Urol 2010;58:191-2 and Giacomo Novara, Vincenzo Ficarra. Does routine second transurethral resection affect the long-term outcome of patients with T1 bladder cancer? Why a flawed randomized controlled trial cannot address the issue. Eur Urol 2010;58:193-4. Divrik RT; Sahin AF; Ergör G Eur Urol; 2010 Aug; 58(2):195-6. PubMed ID: 20471156 [No Abstract] [Full Text] [Related]
6. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. Richards KA; Smith ND; Steinberg GD J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761 [TBL] [Abstract][Full Text] [Related]
7. The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Li C; Gao L; Zhang J; Yang X; Liu C Lasers Med Sci; 2020 Jul; 35(5):1025-1034. PubMed ID: 32006262 [TBL] [Abstract][Full Text] [Related]
8. Use of surgical checklist during transurethral resection increases detrusor muscle collection rate and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer. Taoka R; Tsunemori H; Matsuoka Y; Kohashiguchi K; Miura T; Tohi Y; Miyauchi Y; Kato T; Ueda N; Sugimoto M Int J Urol; 2021 Jul; 28(7):727-732. PubMed ID: 33742465 [TBL] [Abstract][Full Text] [Related]
9. [Repeat transurethral resection for non-muscle invasive bladder cancer]. Shen YJ; Ye DW; Yao XD; Zhang SL; Dai B; Zhu YP; Zhang HL; Zhu Y; Shi GH; Ma CG Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):725-7. PubMed ID: 19615201 [TBL] [Abstract][Full Text] [Related]
10. Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36. Vila-Reyes H; Joel DeCastro G; McKiernan JM Eur Urol; 2021 Feb; 79(2):e54-e55. PubMed ID: 33248798 [No Abstract] [Full Text] [Related]
11. Re: Francesco Del Giudice, Giovanni Barchetti, Ettore De Berardinis, et al. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Eur Urol 2020;77:101-9. Fragkoulis C; Papadopoulos G; Ntoumas K Eur Urol; 2020 Apr; 77(4):e93. PubMed ID: 31980311 [No Abstract] [Full Text] [Related]
12. Re: Hugh Mostafid, Ashish M. Kamat, Siamak Daneshmand, et al. Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours. Eur Urol Oncol 2021;4:12-9. Montorsi F; Bandini M; Moschini M; Dehò F; Gallina A Eur Urol Oncol; 2021 Feb; 4(1):126. PubMed ID: 33309069 [No Abstract] [Full Text] [Related]
13. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526 [TBL] [Abstract][Full Text] [Related]
14. Re: Richard J. Sylvester, Willem Oosterlinck. An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed? Eur Urol 2009;56;43-5. Gudjónsson S; Månsson W; Holmäng S; Liedberg F Eur Urol; 2010 Mar; 57(3):e28-9; author reply e30. PubMed ID: 19931978 [No Abstract] [Full Text] [Related]
15. Reply to Arnulf Stenzl, Morgan Rouprêt, J. Alfred Witjes, Paolo Gontero. High-quality Transurethral Resection of Bladder Tumour Needs Additional Forms of Tumour Delineation. Eur Urol 2023;83:193-4. Heer R; Tan WS; Gravestock P; Vadiveloo T; Lewis R; Penegar S; Vale L; MacLennan G; Hall E; Eur Urol; 2024 Mar; 85(3):309-312. PubMed ID: 37330372 [No Abstract] [Full Text] [Related]
16. [A second transurethral resection could be not necessary in all high grade non-muscle-invasive bladder tumors]. Gaya JM; Palou J; Cosentino M; Patiño D; Rodríguez-Faba O; Villavicencio H Actas Urol Esp; 2012 Oct; 36(9):539-44. PubMed ID: 22710093 [TBL] [Abstract][Full Text] [Related]
17. Bladder preservation strategy based on combined therapy in patients with muscle-invasive bladder cancer: management and results at long-term follow-up. Villavicencio H; Rodriguez Faba O; Palou J; Gausa L; Algaba F; Marcuello E Urol Int; 2010; 85(3):281-6. PubMed ID: 20689253 [TBL] [Abstract][Full Text] [Related]
18. Innovative technique in nonmuscle invasive bladder cancer-bipolar plasma vaporization. Geavlete B; Multescu R; Georgescu D; Jecu M; Dragutescu M; Geavlete P Urology; 2011 Apr; 77(4):849-54. PubMed ID: 21167565 [TBL] [Abstract][Full Text] [Related]
19. A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer. Hayashida Y; Miyata Y; Matsuo T; Ohba K; Sakai H; Taba M; Naito S; Taniguchi K BMC Urol; 2019 Jun; 19(1):56. PubMed ID: 31234817 [TBL] [Abstract][Full Text] [Related]
20. Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer. Kuczyk M; Machtens S; Bokemeyer C; Kollmannsberger C; Hartmann J; Kondoh M; Merseburger A; Jonas U World J Urol; 2002 Aug; 20(3):183-9. PubMed ID: 12196902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]